Overview
DIA brings you a symposium with interactive dynamics, where you will engage in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America. Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape.
Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.
We will be translating:
- English to Spanish and Portuguese
- Spanish to English and Portuguese
- Portuguese to English and Spanish
LETTER TO SUPPORT YOUR US VISA APPLICATION
DIA can provide a letter to confirm your onsite participation as long as you have:
- Already registered for this conference and
- Paid the registration for this conference
To request a confirmation letter please send an email to Megan Stevens at Megan.Stevens@diaglobal.org.
On-Demand Content Preview Webinar
The US FDA Generic Drug Program – The Framework to "Sameness"Gain an overview of the legal framework for how generic drugs can be developed for approval in the United States, and more.
Register today.
New Podcast!
Promoting Patient-Centric Business: MedComm in Latin AmericaHear Barbara Nardi, Associate Director of Medical Communications, PPD, Brazil, and Emanuela Lopes Fernandes Saraiva, Customer Service and Medical Information Manager in Pharmacovigilance, Libbs Farmaceutica, Brazil, discuss topics from DIA's Latin America Medical Information and Communication Workshop.
Listen in.
Featured
Who should attend?
Professionals involved in:
- Drug regulation
- Clinical research and development
- Medical and scientific affairs
- Quality assurance
- Research and development
- Strategic sourcing/planning
- Regulatory affairs
Learning objectives
At the conclusion of this conference, participants should be able to:
- Discuss various initiatives related to global regulatory convergence and harmonization and their impact on the access of medicines and future R&D in Latin America
- Examine various approaches and best practices to ensure regulatory reliance in Latin America
Program Committee
-
Mario Alanis, PhD • Senior Advisor
Centre for Innovation in Regulatory Science (CIRS), United Kingdom -
Peter Baker • International Relations Specialist, OIP, OGROP
FDA, United States -
Maria Guazzaroni Jacobs, PhD • Director, Quality Intelligence, Global Supply
Pfizer Inc, United States -
Maria Cristina Mota Pina, MBA • Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
Latin America Federation of Pharmaceutical Industry (FIFARMA), United States -
Jaime Oliveira, DrPH, AHIP • Head Regulatory Policy and Intelligence LatAm
Bayer S.A., Brazil -
Patricia Oliveira Pereira Tagliari, LLM, MPH • Associate Director
Brazilian Health Regulatory Agency - ANVISA, Brazil -
Ana Padua, MSc, RPh • Associate Director GRA CMC Regulatory Intelligence Biopharam Global Regulatory
EMD Serono, Switzerland -
Ana Pineda Zavaleta, MSc • International Regulatory Analyst, OIP, OGROP, OC
FDA, United States -
Analia Porras • Unit Chief, Medicines and Health Technologies
Pan American Health Organization (PAHO), United States
